93 related articles for article (PubMed ID: 3621224)
21. Single-dose dacarbazine and dactinomycin in advanced malignant melanoma.
Hochster H; Levin M; Speyer J; Dunleavy S; Harris M; Roses D; Golomb F; Muggia F
Cancer Treat Rep; 1985 Jan; 69(1):39-42. PubMed ID: 3967259
[TBL] [Abstract][Full Text] [Related]
22. Phase II trial of dacarbazine and thalidomide for the treatment of metastatic melanoma.
Ott PA; Chang JL; Oratz R; Jones A; Farrell K; Muggia F; Pavlick AC
Chemotherapy; 2009; 55(4):221-7. PubMed ID: 19451711
[TBL] [Abstract][Full Text] [Related]
23. Dacarbazine DTIC and carboplatin as an outpatient treatment for disseminated malignant melanoma.
Nieboer P; Mulder NH; Van Der Graaf WT; Willemse PH; Hospers GA
Anticancer Res; 2001; 21(4B):3115-6. PubMed ID: 11712820
[TBL] [Abstract][Full Text] [Related]
24. Dacarbazine-based chemotherapy for metastatic melanoma: thirty-year experience overview.
Serrone L; Zeuli M; Sega FM; Cognetti F
J Exp Clin Cancer Res; 2000 Mar; 19(1):21-34. PubMed ID: 10840932
[TBL] [Abstract][Full Text] [Related]
25. A randomized phase III study comparing dacarbazine, BCNU, cisplatin and tamoxifen with dacarbazine and interferon in advanced melanoma.
Middleton MR; Lorigan P; Owen J; Ashcroft L; Lee SM; Harper P; Thatcher N
Br J Cancer; 2000 Mar; 82(6):1158-62. PubMed ID: 10735499
[TBL] [Abstract][Full Text] [Related]
26. A phase II study of chemoneuroimmunotherapy with platinum, subcutaneous low-dose interleukin-2 and the pineal neurohormone melatonin (P.I.M.) as a second-line therapy in metastatic melanoma patients progressing on dacarbazine plus interferon-alpha.
Lissoni P; Vaghi M; Ardizzoia A; Malugani F; Fumagalli E; Bordin V; Fumagalli L; Bordoni A; Mengo S; Gardani GS; Tancini G
In Vivo; 2002; 16(2):93-6. PubMed ID: 12073777
[TBL] [Abstract][Full Text] [Related]
27. A phase II study evaluating the effect of tamoxifen on DNA repair in melanoma patients treated with dacarbazine.
Saunders MP; Salisbury AJ; O'Byrne KJ; Souliotis VL; Varcoe SM; Talbot DC; Kyrtopoulos SA; Harris AL
Anticancer Res; 1997; 17(6D):4677-80. PubMed ID: 9494588
[TBL] [Abstract][Full Text] [Related]
28. Acute myocardial infarction induced by cisplatin-based combination chemotherapy for malignant melanoma: a case report.
Fukunaga T; Soejima H; Sugamura K; Kojima S; Sugiyama S; Sakamoto T; Yoshimura M; Tanoue T; Kageshita T; Ono T; Ogawa H
J Cardiol; 2006 Apr; 47(4):191-5. PubMed ID: 16637253
[TBL] [Abstract][Full Text] [Related]
29. [Case of metastatic malignant melanoma responded to combination chemotherapy with DTIC].
Tamura T; Miyamoto H; Harada M; Makinoya T; Yamamoto M; Miyoshi Y; Komi N
Gan To Kagaku Ryoho; 1984 Feb; 11(2):327-32. PubMed ID: 6582806
[TBL] [Abstract][Full Text] [Related]
30. What can we learn from phase II adjuvant trials in melanoma?
Keilholz U; Suciu S; Eggermont AM
Br J Cancer; 2000 Jul; 83(1):6-7. PubMed ID: 10883660
[No Abstract] [Full Text] [Related]
31. Outpatient chemoimmunotherapy for the treatment of metastatic melanoma.
Thompson JA; Gold PJ; Fefer A
Semin Oncol; 1997 Feb; 24(1 Suppl 4):S44-8. PubMed ID: 9122734
[TBL] [Abstract][Full Text] [Related]
32. A prospective single arm phase II study of dacarbazine and treosulfan as first-line therapy in metastatic uveal melanoma.
O'Neill PA; Butt M; Eswar CV; Gillis P; Marshall E
Melanoma Res; 2006 Jun; 16(3):245-8. PubMed ID: 16718271
[TBL] [Abstract][Full Text] [Related]
33. [Combination of fotemustine-dacarbazine and interferon alpha in the treatment of metastatic malignant melanoma].
Célérier P; Dreno B; Bureau B; Litoux P
Ann Dermatol Venereol; 1993; 120(6-7):437-40. PubMed ID: 8279787
[TBL] [Abstract][Full Text] [Related]
34. [Adjuvant chemotherapy as a component of complex treatment for skin melanoma].
Kudriavtsev DV; Kudriavtseva GT; Mardynskiĭ IuS
Vopr Onkol; 2008; 54(2):170-7. PubMed ID: 18522165
[TBL] [Abstract][Full Text] [Related]
35. Tamoxifen and chemotherapy for refractory metastatic malignant melanoma.
McKeage MJ; Lorentzos A; Gore ME
N Engl J Med; 1993 Jan; 328(2):140-1. PubMed ID: 8416433
[No Abstract] [Full Text] [Related]
36. High-dose cisplatin and dacarbazine in the treatment of metastatic melanoma.
Luger SM; Kirkwood JM; Ernstoff MS; Vlock DR
J Natl Cancer Inst; 1990 Dec; 82(24):1934-7. PubMed ID: 2250315
[No Abstract] [Full Text] [Related]
37. Three-drug combination of cisplatin, dacarbazine, and tamoxifen in metastatic malignant melanoma.
Chmielowska E; Potemski P; Pluzańska A
J Clin Oncol; 1995 Aug; 13(8):2146-7. PubMed ID: 7636562
[No Abstract] [Full Text] [Related]
38. Combined chemotherapy with or without interferon alpha N1 (IFN) for advanced malignant melanoma--a randomized pilot phase III study.
Gorbonova VA; Egorov GN; Perevodchikova NI; Orel NF
Gan To Kagaku Ryoho; 2000 May; 27 Suppl 2():310-4. PubMed ID: 10939991
[No Abstract] [Full Text] [Related]
39. [Primary malignant melanoma of the female urethra: a case report].
Kajikawa H; Takada M; Seguchi T; Sakaguchi H
Hinyokika Kiyo; 1987 Jan; 33(1):97-100. PubMed ID: 2437781
[TBL] [Abstract][Full Text] [Related]
40. Phase II study of the combination of carmustine and 6-thioguanine in advanced malignant melanoma.
Morton RF; Creagan ET; Veeder MH; Elson DL; Laurie JA; Nelimark RA; Chang MN
Cancer Treat Rep; 1987 Apr; 71(4):429-30. PubMed ID: 3548962
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]